PortfoliosLab logo

Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

Equity · Currency in USD · Last updated Mar 27, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Biohaven Pharmaceutical Holding Company Ltd. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $19,575 for a total return of roughly 95.75%. All prices are adjusted for splits and dividends.


0.00%50.00%100.00%150.00%NovemberDecember2023FebruaryMarch
95.75%
7.52%
BHVN (Biohaven Pharmaceutical Holding Company Ltd.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BHVN

Return

Biohaven Pharmaceutical Holding Company Ltd. had a return of 2.95% year-to-date (YTD) and 95.75% in the last 12 months.


PeriodReturnBenchmark
1 month-6.23%-0.66%
Year-To-Date2.95%3.42%
6 months95.75%7.52%
1 year95.75%7.52%
5 years (annualized)N/AN/A
10 years (annualized)N/AN/A

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202337.54%-19.96%
2022-13.70%163.02%-4.53%-12.26%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The chart below displays rolling 12-month Sharpe Ratio.


Chart placeholderNot enough data

Dividend History


Biohaven Pharmaceutical Holding Company Ltd. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2023FebruaryMarch
-25.57%
-4.99%
BHVN (Biohaven Pharmaceutical Holding Company Ltd.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Biohaven Pharmaceutical Holding Company Ltd.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Biohaven Pharmaceutical Holding Company Ltd. is 32.60%, recorded on Mar 22, 2023. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-32.6%Jan 24, 202341Mar 22, 2023
-25.44%Sep 27, 20224Sep 30, 20223Oct 5, 20227
-24.76%Nov 2, 202238Dec 27, 202210Jan 11, 202348
-21.47%Oct 7, 20227Oct 17, 20224Oct 21, 202211
-10%Jan 17, 20232Jan 18, 20233Jan 23, 20235
-6.46%Oct 25, 20222Oct 26, 20222Oct 28, 20224

Volatility Chart

Current Biohaven Pharmaceutical Holding Company Ltd. volatility is 74.19%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%250.00%NovemberDecember2023FebruaryMarch
74.19%
19.50%
BHVN (Biohaven Pharmaceutical Holding Company Ltd.)
Benchmark (^GSPC)